公开(公告)号：US20250136613A1

公开(公告)日：2025-05-01

申请号：US18835370

申请日：2022-11-04

Applicant: Osaka University

Inventor： Satoshi OBIKA ,  Osamu NAKAGAWA ,  Ryohei YAMAJI ,  Haruhiko KAMADA ,  Taisuke NAKAYAMA

IPC: C07D498/04 ,  A61K47/54 ,  C07F9/6561 ,  C07H19/23

Abstract: A compound or a pharmaceutically acceptable salt thereof according to the present invention has a structure represented by Formula (I) and can form a ligand for a drug delivery system formulation. The drug delivery system formulation according to the present invention can improve, for example, an ability to make a delivery to the skeletal muscle.